Lumida
/DCTH
⌘K
Delcath Systems Inc

Delcath Systems Inc

DCTH
$15.91USD+0.70%+0.11 today

MARKET CAP

552.1M

P/E (TTM)

1,591.0x

FWD P/E

DAY RANGE

$16 – $16

52W RANGE

$8
$17

AI Summary

Stalk
StalkMedium

DCTH remains in a Stage 2 advancing phase with long- and medium-term uptrends intact. However, price is extended and marked as extremely overbought, consolidating above the rising EMAs without a clear upside trigger. Execution is deferred until a pullback into the 9/21 EMA support zone resolves, offering a lower-risk entry aligned with the advancing structure.

  • Shares rose ~52% Q/Q and ~51% Y/Y, outpacing the S&P 500
  • Earnings estimates revised from -$0.88 to -$0.17, indicating improvement
  • Earnings yield -1.99 and weak profitability indicate losses
Full analysis →

Buying

4

institutions

Selling

5

institutions

New Positions

0

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

InstitutionActionShares HeldValueChangeChg %Weight
BI

Blackrock, Inc.

Q2 2026

BUY2.71 M34.08 M+922.34 K+105.8%0.00%
MM

Millennium Management LLC

Q2 2026

SELL566.37 K7.13 M+-21.68 K+30.7%0.00%
AC

Aqr Capital Management LLC

Q2 2026

BUY172.99 K2.18 M+140.90 K+631.2%0.00%
MG

Man Group Plc

Q2 2026

BUY128.50 K1.62 M+26.28 K+70.5%0.00%
CA

Citadel Advisors LLC

Q2 2026

SELL57.74 K726.98 K+-123.02 K-56.7%0.00%
BA

Balyasny Asset Management L.P.

Q2 2026

SELL28.47 K358.41 K+-10.06 K+0.3%0.00%
JC

Jpmorgan Chase & Co

Q2 2026

SELL12.94 K167.55 K+-237.00+43.0%0.00%
RC

Rockefeller Capital Management L.P.

Q2 2026

BUY755.009.51 K+200.00+84.6%0.00%
RT

Renaissance Technologies LLC

Q2 2026

SELL0.000.00+-155.30 K-100.0%0.00%